A multicentre open label non-comparative phase-IV study to evaluate safety, tolerability and anti-PRP-T antibody Persistence of BEâ??s Combined Liquid Pentavalent DTwP-rHepB-HIB vaccine in 6-8 week old infants as per routine EPI Immunization Schedule - None
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Dec 2017
At a glance
- Drugs Hib-DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Biological E Limited
- 15 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 03 Apr 2017 Status changed from not yet recruiting to recruiting.
- 07 Mar 2017 New trial record